A Phase II Study of Gemcitabine and Docetaxel in Combination for Advanced Pancreatic Cancer

Manuscripts/Articles:

• Schneider B, Ganjoo K, Seitz D, Picus J, Fata F, Stoner C, Calley, C, Loehrer P. Phase II study of gemcitabine and docetaxel in combination for advanced pancreatic cancer-a Hoosier Oncology Group study GI99-1. Oncology. 65(3):218-23, 2003. See abstract.